CD8A and neoplasm: These data show that hRT/lena treatment increases the numbers of tumor-specific CD8+ T cells, especially in the abscopal tumor, and the increased tumor-specific CD8+ T cell frequencies in the TDLNs at both the primary and the secondary sites suggested better CD8+ T cell priming or activation.